STAAR Surgical | STAA - Cash And Equivalent


STAAR Surgical reported $133.61M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Abbott USD 4.05B 1.05B Sep/2026
Bausch Health Companies USD 2.49B 660M Sep/2026
Boston Scientific USD 609M 70M Sep/2026
Cerus USD 19.96M 4.29M Dec/2025
Cooper Companies USD 138.8M 13.9M Mar/2026
J&J USD 16.91B 3.51B Sep/2026
Merit Medical Systems USD 503.55M 54.85M Sep/2026
Novartis USD 8.87B 1.25B Sep/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Orthofix International USD 103.81M 16.47M Jun/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 133.61M 14.97M Sep/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025